Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings.
$1.05+3.96%
报价 2026-11-06
市值
$54.5M
EV
$10.5M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -28.6%
$0.72$1.47
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| TLPHTalphera, Inc. | $54.5M | +4.0% | +29430.6% | -4,075% | – | – | – | |
| NTRBNutriband Inc. | $67.5M | -0.4% | +3433.3% | 33.1% | – | – | – | |
| IBIOiBio, Inc. | $47.5M | +1.2% | -50.0% | -160% | – | – | – | |
| COSMCosmos Health Inc. | $30.7M | +5.2% | +60.2% | 10.3% | – | – | – | |
| MIRAMIRA Pharmaceuticals, Inc. | $24M | +5.6% | – | 0% | – | – | – | |
| SCYXSCYNEXIS, Inc. | $22M | +6.1% | -87.9% | 100% | – | – | – | |
| RVPRetractable Technologies, Inc. | $16.9M | -0.1% | – | – | – | – | – | |
| PIIIP3 Health Partners Inc. | $13.1M | +4.7% | +7.8% | 50.6% | – | – | – | |
| INTSIntensity Therapeutics, Inc. | $8.1M | -3.2% | – | 0% | – | – | – | |
| 同行中位数 | – | – | +7.8% | 10.3% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。